History of aspirin and its mechanism of action

Stroke

Volumn 21, Issue 12, 1990, Pages IV-12-IV-23

  Vane, John R ^a   Flower, Roderick J ^a   Botting, Regina M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Aspirin; Prostaglandins

Indexed keywords

ACETYLSALICYLIC ACID;

CEREBROVASCULAR DISEASE; CONFERENCE PAPER; DRUG MECHANISM; HISTORY OF MEDICINE; HUMAN; PRIORITY JOURNAL;

ANIMAL; ASPIRIN; CYCLOOXYGENASE INHIBITORS; ENZYME INHIBITORS; HISTORY OF MEDICINE, 18TH CENT.; HISTORY OF MEDICINE, 19TH CENT.; HISTORY OF MEDICINE, 20TH CENT.; HISTORY OF MEDICINE, ANCIENT; HISTORY OF MEDICINE, MEDIEVAL; HUMAN; PORTRAITS; PROSTAGLANDINS; SUPPORT, NON-U.S. GOV'T;

EID: 0025694966     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: None     Document Type: Article

References (138)

1. Stone E: An account of the success of the bark of the willow in the cure of agues. Philos Trans R Soc Lond 1763;53:195-200
2. Maclagan TJ: The treatment of acute rheumatism by salicin. Lancet 1876;1:342, 383
3. Strieker S: (abstract) Dublin J Med Sci 1876;52:395-396, reprinted from Berl Klin Wochenschr 1876;13:1-2, 15-16, 99-103
4. Dreser H: Pharmacologisches über Aspirin (Acetylsalicyl-saüre). Pflugers Arch 1899;76:306-318
5. Flower RJ: Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev 1974;26:33-67
6. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for Aspirin-like drugs. Nature New Biol 1971;231:232-235
7. Beecher HK, Keats AS, Mosteller F, Lasagna L: The effectiveness of oral analgesics (morphine, codeine, acetyl-salicylic acid) and the problem of placebo “reactors” and “non-reactors.” J Pharmacol 1953; 109:393-400
8. Sherman H, Fiasconaro JE, Grundfest H: Laboratory evaluation of analgesic effectiveness in human subjects. Exp Neurol 1963;7:435-456
9. Beaver WT: Mild analgesics: A review of their clinical pharmacology. Am J Med Sci 1965;250:577-604
10. Woodbury DM: Analgesics-antipyretics, anti-inflammatory agents, and inhibitors of uric acid synthesis, in Goodman LS, Gilman A (eds): The Pharmacological Basis of Therapeutics. London, Collier-MacMillan Ltd, 1970, pp 314-347
11. Lim RKS: Salicylate analgesia, in Smith MJH, Smith PK (eds): The Salicylates. New York/London/Sydney, Smith Interscience Publishers, 1966, p 155
12. Hesse E, Roesler G, Bühler F: Zur biologischen Wertbestimmung der Analgetika und ihrer Kombinationen. Naunyn Schmeidebergs Arch Exp Pathol Pharmakol 1930;158:247-253
13. Randall LO, Selitto JJ: A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn 1957;111:409-419
14. Pardo EG, Rodriguez R: Reversal by acetylsalicylic acid of paininduced functional impairment. Life Sci 1966;5:775-781
15. Margolin S: A simple method for the simultaneous determination of the anti-inflammatory and analgesic properties of drugs, in Garattini S, Dukes MNG (eds): Non-steroidal Anti-inflammatory Drugs. Amster dam, Excerpta Medica, 1965, pp 214-217
16. Gilfoil TM, Klavins I, Grumbach L: Effects of acetylsalicylic acid on the oedema and hyperesthesia of the experimentally inflamed rat’s paw. J Pharmacol Exp Ther 1963;142:1-5
17. Winter CA: The physiology and pharmacology of pain and its relief, in Stevens G (ed): Medicinal Chemistry: Analgesics. New York/London Academic Press, 1965, pp 9-74
18. Winter CA, Flataker L: Nociceptive thresholds as affected by parent-eral administration of irritants and of various anti-nociceptive drugs. J Pharmacol Exp Ther 1965;148:373- 379
19. Keith EF: Evaluation of analgesic substances. Am J Pharmacol 1960; 132:202-230
20. Collier HOJ, Dineen LC, Johnson CA, Schneider C: The abdominal constriction response and its suppression by analgesic drugs in the mouse. BrJ Pharmacol 1968;32:295-310
21. Emele JF, Shanaman J: Bradykinin writhing: Method for measuring analgesia. Proc Soc Exp Biol (NY) 1963;114:680-682
22. Collier HOJ, Chesher GB: Antipyretic and analgesic properties of 2 hydroxyisophthalic acids. Br J Pharmacol 1956;11:20-26
23. Guzman F, Braun C, Lim RKS, Potter GD, Rodgers DW: Narcotic and non-narcotic analgesics which block visceral pain evoked by intra-arterial injections of bradykinin and other algesic agents. Arch Int Pharmacodyn 1964;149:571-588
24. Lim RKS, Guzman F, Rodgers DW, Goto K, Braun C, Dickerson GD, Engle RJ: Site of action of narcotic and non-narcotic analgesics determined by blocking bradykinin-evoked visceral pain. Arch Int Pharmacodyn 1964;152:25-58
25. Whittle BA: The use of changes in capillary permeability in mice to distinguish between narcotic and non-narcotic analgesics. Br J Pharmacol 1964;22:246-253
26. Scott D Jr: Aspirin action on receptor in the tooth. Science 1968;161: 180-181
27. Whitehouse MW, Haslam JM: Ability of some antirheumatic drugs to uncouple oxidative phosphorylation. Nature 1962;196:1323-1324
28. Hines WJW, Smith MJH: Inhibition of dehydrogenases by salicylate. Nature 1964;201:192
29. Smith MJH, Bryant C, Hines WJW: Reversal by nicotinamide adenine dinucleotide of the inhibitory action of salicylate on mitochondrial malate dehydrogenase. Nature 1964;202:96-97
30. Gould BJ, Smith MJH: Salicylate and aminotransferases, J Pharm Pharmacol 1965;17:83-88
31. Gould BJ, Smith MJH: Inhibition of rat brain glutamate decarboxylase activity by salicylate in vitro. J Pharm Pharmacol 1965;17:15-18
32. Weiss MP, Campbell PL, Diebler GE, Sokoloff L: Effects of salicylate on amino acid incorporation into protein, J Pharmacol Exp Ther 1962;136:366-371
33. Whitehouse MW: Some biochemical and pharmacological properties of ami-inflammatory drags. Prog Drug Res 1965;8:321-429
34. Spector WG, Willoughby DA: Anti-inflammaiory effects of salicylate in the rat, in Dixon A St JT Martin BK, Smith MJH, Wood PHN (eds): Salicylates: An International Symposium. Boston, Little, Brown, & Co, 1963, pp 141-147
35. Collier HOJ: Aspirin. Sci Am 1963;209:97-108
36. Collier HOJ: A pharmacological analysis of Aspirin. Adv Pharmacol Chemother 1969;7:333-405
37. Collier HOJ, Shorley PG: Analgesic antipyretic drags as antagonists of bradykinin. Br J Pharmacol 1960;15:601-610
38. Collier HOJ, James GWL, Schneider C: Antagonism by Aspirin and fenamates of bronchoconstriclion and nociception induced by adenosine-5-triphasphate. Nature 1966;212:411-412
39. Berry PA, Collier HOJ: Bronchoconstrictor action and antagonism of a slow reacting substance from anaphylaxis of guinea-pig isolated lung. Br J Pharmacol 1964;23:201-216
40. Bhoola KD, Collier HOJ, Schachter M. Shorley PG: Actions of some peptides in bronchial muscle, BrJ Pharmacol 1962;19:190-197
41. Collier HOJ, Sweatman WJF: Antagonism by fenamates of prostaglandin F2a and of slow reacting substance on human bronchial muscle. Nature 1968;219:864-865
42. Piper PJ, Vane JR: Release of additional factors in anaphylaxis and its antagonism by ami-inflammatory drugs. Nature 1969;223:29-35
43. Vane JR: The use of isolated organs for detecting active substances in the circulating blood. BrJ Pharmacol Chemothcr 1964;23:360-373
44. Hamberg M, Svensson J, Samuelsson B: Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Nad Acad Sci USA 1975;72:2994-2998
45. Collier HOJ, James GWL, Piper PJ: Antagonism by fenamates and like-acting drugs of bronchoconstriction induced by bradykinin or antigen in the guinea-pig. Br J Pharmacol 1968;34:76-87
46. Collier HOJ, Dinneen LC, Perkins AC, Piper PJ: Curtailment by Aspirin and meclofenamate of hypotension induced by bradykinin in the guinea-pig. Naunyn Schmiedebergs Arch Pharmacol 1968;259: 159-160
47. Piper PJ, Vane JR: THe release of prostaglandins during anaphylaxis in guinea-pig isolated lungs, in Mantegazza P, Horton EW (eds): Prostaglandins, Peptides and Amines. London/New York, Academic Press, 1969, pp 15-19
48. Gilmore N, Vane JR, Wyllie JH: Prostaglandin release by the spleen in response to infusion of particles, in Mantegazza P, Horton EW (eds): Prostaglandins, Peptides and Amines. London/New York, Academic Press, 1969, pp 21-29
49. Palmer MA, Piper PJ, Vane JR: The release of RCS from chopped lung and its antagonism by anti-inflammatory drugs. Br J Pharmacol 1970;40:581P
50. Palrner MA, Piper PJ, Vane JR: Release of vaso-active substances from lungs by injection of particles. Br J Pharmacol 1970;40:547P
51. Vane JR: Mediators of the anaphylactic reaction, in Identification of Asthma. CIBA Foundation Study No 38, Edinburgh/London, Churchill Livingstone, 1971, pp 121-131
52. Vane JR: The release and fate of vaso-active hormones in the circulation. Br J Pharmacol 1969;35:209-242
53. Piper PJ, Vane JR: The release of prostaglandins from lung and other tissues. Ann NY Acad Sci USA 1971;180:353-385
54. Anggard E, Samuelsson B: Biosynthesis of prostaglandins from arachidonic acid in guinea-pig lung. J Biol Chem 1965;240:3518-3521
55. Smith JB, Willis AL: Aspirin selectively inhibits prostaglandin production in human platelets. Nature 1971;231:235-237
56. Ferreira SH, Moncada S, Vane JR: Indomethacin and Aspirin abolish prostaglandin release from spleen. Nature 1971;231:237-239
57. Milton AS, Wendlandt S: A possible role for prostaglandin E1 as a modulator of temperature regulation in the central nervous system of the cat. J Physiol 1970;207:76-77
58. Solomon LM, Juhlin L, Kirschbaum MB: Prostaglandins in cutaneous vasculalure. J Invest Derm 1968;51:280-282
59. Di Rosa M, Giraud JP, Willoughby DA: Studies of the mediators of the acute inflammatory response induced in rats in different sites by carragecnin and turpentine. J Pathot 1971;104:15-29
60. Flower R, Gryglewski R. Herbaczynska-Ccdro K, Vane JR: The effects of anti-inflammatory drugs on a cell-free prostaglandin synthetase system from dog spleen. Nature 1972;238:104-106
61. Smith WL, Lands WEM: Stimulation and blockade of prostaglandin biosynthesis. J Biol Chem 1971;246:6700
62. Tomlinson RV, Ringold HJ, Qureshi MC, Forchielli E: Relationship between inhibition of proslaglandin synthesis and drug efficacy: Support for the current theory on mode of action of Aspirin-like drugs. Biochem Biophys Res Commun 1972;46:552-559
63. Collier JC, Flower RJ: Effect of Aspirin on human seminal prostaglandins. Lancet 1971;2:852-853
64. Aiken JW, Vane JR: Blockade of angiotensin induced prostaglandin release from dog kidney by indomethacin. Pharmacologist 1971;13:564
65. Aiken JW, Vane JR: Intra-renal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. J Pharmacol Exp Ther 1973;184:678-687
66. Herbaczynska-Cedro K, Vane JR: An intra-renal role for proslaglandin production (abstract). Proceedings of the Fifth International Congress on Pharmaoclogy, San Francisco, 1972
67. Davis H, Horton EW: Output of prostaglandins from the rabbit kidney, its increase on renal nerve stimulation and inhibition by indomethacin, BrJ Pharmacol 1972;46:658-675
68. Ferreira SH, Moncada S: Inhibition of proslaglandin synthesis augments the effects of sympathetic nerve stimulation on the cat spleen. Br J Pharmacol 1971;43:491
69. Gryglewski R, Vane JR: The release of prostaglandins and rabbit aorta contracting substance (RCS) from rabbit spleen and its antagonism by anti-inflammatory drugs. Br J Pharmacol 1972;45:37-47
70. Ferreira SH, Herman A, Vane JR: Prostaglandin generation maintains the smooth muscle tone of the rabbit isolated jejunum. Br J Pharmacol 1972;44:328
71. Herman AG, Eckenfels A, Ferreira SH, Vane JR: Relationship between tone of isolated smooth muscle preparations and production of prostaglandins (abstract). Proceedings of the Fifth International Congress on Pharmacology, San Francisco, 1972
72. Aiken JW: Aspirin and indomethacin prolong parturition in rats: Evidence that prostaglandins contribute to expulsion of fetus. Nature 1972;240:21-25
73. Vane JR, Williams KI: Prostaglandin production contributes to the contractions of the rat isolated uterus. Br J Pharmacol 1972;45:146
74. Sykes JAC, Maddox IS: Prostaglandin production by experimental tumours and effects of anti-inflammatory compounds. Nature 1972;237: 59-61
75. Levine L: Prostaglandin production by mouse fibrosarcoma cells in culture: Inhibition by indomethacin and Aspirin. Biochem Biophys Res Commun 1972;47:888-896
76. Davis HA: Output of prostaglandins from the rabbit kidney (abstract). Advance Abstracts, International Conference on Prostaglandins, Vienna, 1972
77. Tai HH, Hollander CS: Regulation of prostaglandin synthetase activity in rabbit kidney medulla: A possible mechanism of hormonal and drug action (abstract). Advance Abstracts, International Conference on Prostaglandins, Vienna, 1972
78. Somova L: Inhibition of prostaglandin synthesis in the kidneys by Aspirin-like drugs. Adv Biosd 1972;9:335-339
79. Milton AS: Prostaglandin E1 and endotoxin fever, and the effects of Aspirin, indomethacin, and 4-acetamidophenol. Adv Biosd 1973;9: 495-500
80. Ziboh VA: Biosynthesis of prostaglandin E2 in human skin: Subcellular localization and inhibition by unsaturated fatty acids and antiinflammatory agents. J Lipid Res 1973;14:377-384
81. Poyser NL: The formation of prostaglandins by the guinea-pig uterus and the effect of indomethacin. Adv Biosd 1973;9:631-634
82. Rower RJ, Vane JR: Inhibition of prostaglandin synthetase in brain explains the antipyretic activity of paracetamol (4-acetamidophenol). Nature 1972;240:410-411
83. Shen TY: Prostaglandin synthetase inhibitors, in Vane JR, Ferreira SH (eds): Anti-inflammatory Drugs. Berlin, Springer, 1979, pp 305-347
84. Lands WEM: Actions of anti-inflammatory drugs. Trends Pharmacol Sci 1981;2:78-80
85. Rome LH, Lands WEM: Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs. Proc Natl Acad Sci USA 1975:72:4863-4865
86. Kulmacz RJ, Lands WEM: Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents. J Biol Chem 1985;23:12572-12578
87. Kulmacz RJ, Ren Y, Tsai A-L, Palmer G: PGH synthase: Interaction with hydroperoxides and indomethacin (abstract). Proceedings of the Seventh International Conference on Prostaglandins and Related Compounds, Florence, 1990
88. Gund P, Shen TY: A model for the prostaglandin synthetase cyclooxygenation site and its inhibition by anti-inflammatory arylacelic acids. J Med 1977;20:1146-1152
89. Appleton RA, Brown K: Conformational requirements at the prostaglandin cyclo-oxygenase receptor site: A template for designing non-steroidal anti-inflammatory drugs. Prostaglandins 1979;18:29-34
90. Marshall PJ, Kulmacz RJ, Lands WEM: Constraints on prostaglandin biosynthesis in tissues. J Biol Chem 1987;262:3510-3517
91. Lands WEM. Cook HW, Rome LH: Prostaglandin biosynthesis: Consequences of oxygenase mechanism upon in vitro assays of drug effectiveness. Adv Proslagiandin Thromb Res 1976;1;7-17
92. Hetnler M. Lands WEM, Smith WL: Purification of the cyclooxygenase that forms prostaglandins: Demonstration of two forms of iron in the holoenzyme. J Biol Chem 1976;251:5575-5579
93. Smith WL: Prostaglandin biosynthesis and its compartmentation in vascular smooth muscle and endothelial cells. Annu Rev Physiol 1986;48:251-262
94. Roth GJ, Majerus PW: The mechanism of the effect of Aspirin on human platelets: 1. Acelylalion of a particulate fraction protein. J Clin Invest 1975;56:624-632
95. Smith WL: The eicosanoids and their biochemical mechanisms of action, Biochem J 1989;259:315-324
96. DeWitt DL, El-Harith EA, Kraemer SA, Andrews MJ, Yao EF, Armstrong RL, Smith WL: The Aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases. J Biol Chem 1990;265:5192-5198
97. Sanduja R, Loose-Mitchell D, Tsai AL, Wu KK: Inhibition of prostaglandin H synthase expression by Aspirin and sodium salicylate: A novel pharmacological mechanism (abstract). Proceedings of the Seventh International Conference on Prostaglandins and Related Compounds, Florence, 1990
98. Rai A, Wyche A, Siegel N, Needleman P: Regulation of fibroblast cyclooxygenase synthesis by interleukin-1. J Biol Chem 1988;263: 3022-3028
99. Masferrer JL, Zweifel BS, Needleman P: In vivo regulation of cyclooxygenase by lipopolysaccharide (LPS) and dexaniethasone (abstract). Proceedings of the Seventh International Conference on Prostaglandins and Related Compounds, Florence, 1990
100. Coyne DW, Morrison AR: Effects of IL-1 and TNF on PGE2 production and cyclooxygenase (COX) activity in rat mesangial cells (abstract). Proceedings of the Seventh International Conference on Prostaglandins and Related Compounds, Florence, 1990
101. Raz A, Wyche A, Needleman P: Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Proc Natl Acad Sci USA 1989;86:1657-1661
102. DeWitt DL, Day JS, Sonnenburg WK, Smith WL: Concentrations of prostaglandin endoperoxide synthase and prostaglandin I2 synthase in the endothelium and smooth muscle of bovine aorta. J Clin Invest 1983;72:1882-1888
103. Markey CM, Alward A, Weller PE, Marnett LJ: Quantitative studies of hydroperoxide reduction by prostaglandin H synthase: Reducing substrate specificity and the relationship of peroxidase to cyclooxygenase activities. J Biol Chem 1987;262:6266-6279
104. Kuehl FA, Humes JL, Ham EA, Egan RW, Dougherty HW: Inflammation: The role of peroxidase-derived products in Samuelsson B, Ramwell PW (eds): Advances in Prostaglandin and Thromboxane Research. New York, Raven Press, Publishers, vol 6, 1980, pp 77-86
105. Karthein R, Dietz R, Nastainczyk W, Ruf HH: Higher oxidation states of prostaglandin H synthase: EPR study of a transient tyrosylradical in the enzyme during the peroxidase reaction. Eur J Biochem 1988;171: 313-320
106. Pedersen AK, FitzGerald GA: Dose-related kinetics of Aspirin: Presystemic acetylation of platelet cyclo-oxygenase. N Engl J Med 1984; 311:1206-1211
107. Moncada S, Ferreira SH, Vane JR: Prostaglandins, Aspirin-like drugs and oedema of inflammation. Nature 1973;246:217-219
108. Higgs GA, Vane JR, Hart FD, Wojtulewski JA: Effects of antiinflammatory drugs on prostaglandins in rheumatoid arthritis, in Robinson HI, Vane JR (eds): Prostaglandin Synthetase Inhibitors. New York, Raven Press, Publishers, 1974, pp 165-173
109. Trang LE, Granstrom E, Lovgren O: Levels of prostaglandin F2a and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis. Scand J Rheumatol 1977;6:151-154
110. Boughton-Smith NK, Whittle BJR: Stimulation and inhibition of prostacyclin formation in the gastric mucosa and ileum in vitro by anti-inflammatory agents. Br J Pharmacol 1983;78:173-180
111. Carson JL, Strom BL, Soper KA, West SL, Morse ML: The association of nonsteroidal antiinflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 1987;147:85-88
112. Boughton-Smith NK, Wallace JL, Morris GP, Whittle BJR: The effect of anti-inflammatory drugs oneicosanoid formation in a chronic model of inflammatory bowel disease in the rat. Br J Pharmacol 1988;94:65-72
113. Whittle BJR, Higgs GA, Eakins KE, Moncada S, Vane JR: Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature 1980;284:271-273
114. Roth S, Agrawal N, Mahowald M, Montoya H, Robbins D, Miller S, Nutting E, Woods E, Crager M, Nissen C: Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving Aspirin. Arch Intern Med 1989;149:775-779
115. Patrono C, Dunn MJ: The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int 1987;32:1-12
116. Schwartzman M, Carroll MA, Ibraham NG, Ferreri NR, Songu-Mize E, McGiff JC: Renal arachidonic acid metabolism: The third pathway. Hypertension 1985;7(suppl I):I-136-I-144
117. Donker AJM, Arisz L, Brentjens JRH, van der Hem GK: Het effect van indometacine i op de glomerulaire filtatie. Ned T Geneesk 1975; 119:815
118. Arisz L, Donker AJM, Brentjens JRH, van der Hem GK: Het effect van indometacine i op de proteinuri bij het nefrotisch syndroom. Ned T Geneesk 1975; 119:815
119. Gribnau FWJ: Studies in Heymann-type nephritis and in puromycin aminonucleoside nephropathy, in Gribnau FWJ (ed): Indomethacin in Experimental Nephritis. Nijmegen, Netherlands, Drukkerij Brakkenstein, 1975
120. Whelton A, Stout RL, Spilman PS, Klassen DK: Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure: A prospective, randomized, crossover comparison. Ann Intern Med1990;112:568-576
121. Lewis LB, Schulman JD: Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet 1973;2:1159-1161
122. Waltman R, Tricomi V, Palav AB: Aspirin and indomethacin: Effect on instillation abortion time of mid-trimester hypertonic saline-induced abortion. Prostaglandins 1973;3:47-58
123. Wiqvist N, Lundstrōm V, Gréen K: Indomethacin and premature labour, in Samuelsson B, Paoletti B (eds): Advances in Prostaglandin and Thromboxane Research. New York, Raven Press, Publishers, vol II, 1976, p998
124. Green K, Drvota V, Vesterqvist O: Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). Prostaglandins 1989;37:311-315
125. Higgs G A, Flower RJ, Vane JR: A new approach to antiinflammatory drugs. Biochem Pharmacol 1979;28; 1959-1961
126. Hamberg M: Inhibition of prostaglandin synthesis in man. Biochem Biophys Res Commun 1972;49:720-726
127. Higgs GA, Salmon JA, Henderson B, Vane JR: Phannacokinetics of Aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and anti-inflammatory activity. Proc Natl Acad Sci USA 1987;84:1417-1420
128. Abramson S, Korchak H, Ludewig R, Edelson H, Haines K, Levin RI, Herman R, Rider L, Kimmel S, Weissman G: Modes of action of Aspirin-like drugs. Proc Nail Acad Sci USA 1983;82:7227-7231
129. Vane JR, Flower RJ, Salmon JA: Inhibitors of arachidonic acid metabolism, with especial reference to the Aspirin-like drugs, in Powels TJ, Bockman RS, Honn KV, Ramwell P (eds): Prostaglandins and Related Lipids: Volume 2, Prostaglandins and Cancer. New York, Alan R Liss, Inc, 1982, pp 21-45
130. Gordon D, Henderson DC, Westwick J: Effects of prostaglandins E2and I2 on human lymphocyte transformation in the absence and presence of inhibitors of prostaglandin biosynthesis. Br J Pharmacol 1979;67:17-22
131. Lewis GP, Barrett ML: Immunosuppressive actions of prostaglandins and the possible increase in chronic inflammation after cyclooxygenase inhibitors. Agents Actions 1986;19:59-65
132. Bottomley KMK, Griffiths RJ, Rising JJ, Steward A: A modified mouse air pouch model for evaluating the effects of compounds on granuloma induced cartilage degradation. Br J Pharmacol 1988;93:627-635
133. DeBrito FB, Holmes MJG, Carney SL, Willoughby DA: Drug effects on a novel model of connective tissue breakdown. Agents Actions 1987;21: 287-290
134. Desa FM, Chander CL, Howat DW, Moore AR, Willoughby DA: Indomethacin and cartilage breakdown. J Pharm Pharmacol 1988;40:667
135. Pettipher ER, Henderson B, Edwards JCW, Higgs GA: Indomethacin enhances proteoglycan loss from articular cartilage in antigen-induced arthritis. Br J Pharmacol 1988;94:341P
136. Bahl AK, Foreman JC, Dale MM: The effect of non-steroidal antiinflammatory drugs on interleukin-1 production (abstract). Proceedings of the Seventh International Conference on Prostaglandins and Related Compounds, Florence, 1990
137. Rashad S, Hemingway A, Rainsford K, Revell P, Low F, Walker F: Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet 1989;2:519-522
138. Ferreira SH, Vane JR: New aspects of the mode of action of non-steroid anti-inflammatory drugs. Annu Rev Pharmacol 1974;14: 57-73